265 related articles for article (PubMed ID: 34468876)
1. Clonal Hematopoiesis of Indeterminate Potential: an Expanding Genetic Cause of Cardiovascular Disease.
Bhattacharya R; Bick AG
Curr Atheroscler Rep; 2021 Sep; 23(11):66. PubMed ID: 34468876
[TBL] [Abstract][Full Text] [Related]
2. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
3. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
4. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease.
Kumar P; Kopecky SL; Yang EH; Oren O
Curr Oncol Rep; 2020 Jul; 22(9):87. PubMed ID: 32643015
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis of indeterminate potential and cardiovascular disease.
Saadatagah S; Ballantyne CM
Transl Res; 2023 May; 255():152-158. PubMed ID: 36067904
[TBL] [Abstract][Full Text] [Related]
7. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
[TBL] [Abstract][Full Text] [Related]
8. Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.
Libby P; Sidlow R; Lin AE; Gupta D; Jones LW; Moslehi J; Zeiher A; Jaiswal S; Schulz C; Blankstein R; Bolton KL; Steensma D; Levine RL; Ebert BL
J Am Coll Cardiol; 2019 Jul; 74(4):567-577. PubMed ID: 31345432
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis and vascular disease.
Amancherla K; Wells JA; Bick AG
Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
[TBL] [Abstract][Full Text] [Related]
10. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
Yu X; Qian N; Wang Y
Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis - Beyond Conventional Cardiovascular Risk Factors.
Zuriaga MA; Fuster JJ
Circ J; 2023 Feb; 87(3):394-400. PubMed ID: 34433749
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
13. Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood.
Schuermans A; Nakao T; Ruan Y; Koyama S; Yu Z; Uddin MM; Haidermota S; Hornsby W; Lewandowski AJ; Bick AG; Niroula A; Jaiswal S; Ebert BL; Natarajan P; Honigberg MC
J Am Heart Assoc; 2023 Jul; 12(13):e030220. PubMed ID: 37345823
[TBL] [Abstract][Full Text] [Related]
14. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
15. Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk.
Murphy AJ; Dragoljevic D; Natarajan P; Wang N
Thromb Haemost; 2022 Sep; 122(9):1435-1442. PubMed ID: 35445383
[TBL] [Abstract][Full Text] [Related]
16. [Clonal hematopoiesis: causes and clinical implications].
Burchert A
Z Gerontol Geriatr; 2023 Feb; 56(1):65-72. PubMed ID: 36662242
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
Menendez-Gonzalez JB; Rodrigues NP
Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
[TBL] [Abstract][Full Text] [Related]
18. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease.
Amorós-Pérez M; Fuster JJ
Atherosclerosis; 2020 Mar; 297():120-126. PubMed ID: 32109665
[TBL] [Abstract][Full Text] [Related]
19. Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events.
Bhattacharya R; Zekavat SM; Uddin MM; Pirruccello J; Niroula A; Gibson C; Griffin GK; Libby P; Ebert BL; Bick A; Natarajan P
JAMA Cardiol; 2021 Sep; 6(9):1069-1077. PubMed ID: 34106216
[TBL] [Abstract][Full Text] [Related]
20. Clonal haematopoiesis and cardiovascular diseases: A growing relationship.
Fawaz S; Mansier O; Pucheu Y; Marti S; Leroy H; Gaufroy A; Broitman J; James C; Couffinhal T
Arch Cardiovasc Dis; 2021 Apr; 114(4):316-324. PubMed ID: 33714721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
